These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18945585)

  • 1. Keep it simple: ranking health states yields values similar to cardinal measurement approaches.
    Craig BM; Busschbach JJ; Salomon JA
    J Clin Epidemiol; 2009 Mar; 62(3):296-305. PubMed ID: 18945585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.
    Craig BM; Busschbach JJ; Salomon JA
    Med Care; 2009 Jun; 47(6):634-41. PubMed ID: 19433996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data.
    Salomon JA
    Popul Health Metr; 2003 Dec; 1(1):12. PubMed ID: 14687419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of health states with rank-based nonmetric multidimensional scaling.
    Krabbe PF; Salomon JA; Murray CJ
    Med Decis Making; 2007; 27(4):395-405. PubMed ID: 17761959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argentine valuation of the EQ-5D health states.
    Augustovski FA; Irazola VE; Velazquez AP; Gibbons L; Craig BM
    Value Health; 2009 Jun; 12(4):587-96. PubMed ID: 19900257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete choice modeling for the quantification of health states: the case of the EQ-5D.
    Stolk EA; Oppe M; Scalone L; Krabbe PF
    Value Health; 2010 Dec; 13(8):1005-13. PubMed ID: 20825618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning effects in time trade-off based valuation of EQ-5D health states.
    Augestad LA; Rand-Hendriksen K; Kristiansen IS; Stavem K
    Value Health; 2012; 15(2):340-5. PubMed ID: 22433766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.
    Badia X; Monserrat S; Roset M; Herdman M
    Qual Life Res; 1999 Jun; 8(4):303-10. PubMed ID: 10472162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain quality of life as measured by utilities.
    Wetherington S; Delong L; Kini S; Veledar E; Schaufele MK; McKenzie-Brown AM; Chen SC
    Pain Med; 2014 May; 15(5):865-70. PubMed ID: 24716656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Niewada M; Wrona W; Busschbach JJ
    Value Health; 2010; 13(2):289-97. PubMed ID: 19744296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Portuguese and UK health state values differ across valuation methods?
    Ferreira LN; Ferreira PL; Rowen D; Brazier JE
    Qual Life Res; 2011 May; 20(4):609-19. PubMed ID: 21061071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.